Back to mobile site

More on BCAB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (6.3 Score)

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioAtla (NQ:BCAB)
Delayed: 3.66 +0.11 (3.10%)
Prev. Close $3.55  
Open$3.49 
52 Wk High$ 
52 Wk Low$ 
Day High$3.70 
Day Low$3.46 
P/E N/A  
EPS$ 
Volume26,773 

Friends, Peers and Foes (?): ACET, ACRV, ARVN, AZN, BCYC (more...)

Jun 5, 2026 04:31 PM Form 4 BioAtla, Inc. For: Mar 11 Filed by: Vasquez Christian
Jun 5, 2026 04:30 PM Form 4 BioAtla, Inc. For: Mar 11 Filed by: Sievers Eric
Jun 5, 2026 04:30 PM Form 4 BioAtla, Inc. For: Mar 12 Filed by: SHORT JAY M PHD
Jun 3, 2026 04:10 PM Form ARS BioAtla, Inc. For: Dec 31
Jun 3, 2026 04:09 PM Form DEFA14A BioAtla, Inc.
Jun 3, 2026 04:07 PM Form DEF 14A BioAtla, Inc. For: Jun 03
May 18, 2026 06:45 AM Context Therapeutics amends BioAtla license deal for CT-202 drug
May 18, 2026 06:45 AM Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 15, 2026 04:10 PM Form 10-Q BioAtla, Inc. For: Mar 31
Apr 29, 2026 04:07 PM Form 10-K/A BioAtla, Inc. For: Dec 31
View All Articles

Entities mentioned with BCAB

View All Entities